The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

When states legalize medical and recreational cannabis, fewer prescriptions for anxiety are filled, but more for depression ...

Mississippi consistently ranks in the top five in the nation for its rates of antipsychotic drugging in nursing homes.

But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness ...

The following is a summary of “Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders ...

In Canada, prescribing potentially inappropriate medications (PIMs)—drugs whose harms may outweigh their benefits, which may be ineffective, or for which a safer alternative exists—remains very common ...

Antipsychotic medications are prescription pharmaceuticals ... Others are more associated with weight gain, and some medications list both weight loss and weight gain as possible side effects. You can ...

Bristol Myers Squibb is the century-old pharmaceutical giant that markets the oral blood thinner Eliquis in partnership with ...

Ponvory, acquired from Janssen, faces similar competitive pressures, with generic versions of similar drugs dominating ... five other second-generation antipsychotics. Fanapt is not favored ...

For this reason, first-line medications for OCD are selective ... It is the only tricyclic antidepressant used to treat OCD. Antipsychotics are often used as augmentation therapy when SSRIs ...

Researchers at the University of Liverpool have captured important evidence across primary and secondary care to explore the barriers to implementing effective structured medication reviews (SMRs).